Cargando…
Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage
Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the therapeutic potential of Nox2 inhibition on superoxid...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468885/ https://www.ncbi.nlm.nih.gov/pubmed/32401607 http://dx.doi.org/10.1152/ajpcell.00389.2019 |
_version_ | 1783578309637963776 |
---|---|
author | Maqbool, Azhar Watt, Nicole T. Haywood, Natalie Viswambharan, Hema Skromna, Anna Makava, Natalia Visnagri, Asjad Shawer, Heba M. Bridge, Katherine Muminov, Shovkat K. Griffin, Kathryn Beech, David J. Wheatcroft, Stephen B. Porter, Karen E. Simmons, Katie J. Sukumar, Piruthivi Shah, Ajay M. Cubbon, Richard M. Kearney, Mark T. Yuldasheva, Nadira Y. |
author_facet | Maqbool, Azhar Watt, Nicole T. Haywood, Natalie Viswambharan, Hema Skromna, Anna Makava, Natalia Visnagri, Asjad Shawer, Heba M. Bridge, Katherine Muminov, Shovkat K. Griffin, Kathryn Beech, David J. Wheatcroft, Stephen B. Porter, Karen E. Simmons, Katie J. Sukumar, Piruthivi Shah, Ajay M. Cubbon, Richard M. Kearney, Mark T. Yuldasheva, Nadira Y. |
author_sort | Maqbool, Azhar |
collection | PubMed |
description | Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the therapeutic potential of Nox2 inhibition on superoxide generation in saphenous vein ECs (SVECs) from patients with advanced atherosclerosis and type 2 diabetes and on vascular function, vascular damage, and lipid deposition in apolipoprotein E-deficient (ApoE(−/−)) mice with EC-specific insulin resistance (ESMIRO). To examine the effect of genetic inhibition of Nox2, ESMIRO mice deficient in ApoE(−/−) and Nox2 (ESMIRO/ApoE(−/−)/Nox2(−/y)) were generated and compared with ESMIRO/ApoE(−/−)/Nox2(+/y) littermates. To examine the effect of pharmacological inhibition of Nox2, we administered gp91dstat or scrambled peptide to ESMIRO/ApoE(−/−) mice. SVECs from diabetic patients had increased expression of Nox2 protein with concomitant increase in superoxide generation, which could be reduced by the Nox2 inhibitor gp91dstat. After 12 wk Western diet, ESMIRO/ApoE(−/−)/Nox2(−/y) mice had reduced EC superoxide generation and greater aortic relaxation to acetylcholine. ESMIRO/ApoE(−/−)/Nox2(−/y) mice developed more lipid deposition in the thoraco-abdominal aorta with multiple foci of elastin fragmentation at the level of the aortic sinus and greater expression of intercellular adhesion molecule-1 (ICAM-1). Gp91dstat reduced EC superoxide and lipid deposition in the thoraco-abdominal aorta of ESMIRO/ApoE(−/−) mice without causing elastin fragmentation or increased ICAM-1 expression. These results demonstrate that insulin resistance is characterized by increased Nox2-derived vascular superoxide. Complete deletion of Nox2 in mice with EC insulin resistance exacerbates, whereas partial pharmacological Nox2 inhibition protects against, insulin resistance-induced vascular damage. |
format | Online Article Text |
id | pubmed-7468885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Physiological Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-74688852020-09-14 Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage Maqbool, Azhar Watt, Nicole T. Haywood, Natalie Viswambharan, Hema Skromna, Anna Makava, Natalia Visnagri, Asjad Shawer, Heba M. Bridge, Katherine Muminov, Shovkat K. Griffin, Kathryn Beech, David J. Wheatcroft, Stephen B. Porter, Karen E. Simmons, Katie J. Sukumar, Piruthivi Shah, Ajay M. Cubbon, Richard M. Kearney, Mark T. Yuldasheva, Nadira Y. Am J Physiol Cell Physiol Research Article Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the therapeutic potential of Nox2 inhibition on superoxide generation in saphenous vein ECs (SVECs) from patients with advanced atherosclerosis and type 2 diabetes and on vascular function, vascular damage, and lipid deposition in apolipoprotein E-deficient (ApoE(−/−)) mice with EC-specific insulin resistance (ESMIRO). To examine the effect of genetic inhibition of Nox2, ESMIRO mice deficient in ApoE(−/−) and Nox2 (ESMIRO/ApoE(−/−)/Nox2(−/y)) were generated and compared with ESMIRO/ApoE(−/−)/Nox2(+/y) littermates. To examine the effect of pharmacological inhibition of Nox2, we administered gp91dstat or scrambled peptide to ESMIRO/ApoE(−/−) mice. SVECs from diabetic patients had increased expression of Nox2 protein with concomitant increase in superoxide generation, which could be reduced by the Nox2 inhibitor gp91dstat. After 12 wk Western diet, ESMIRO/ApoE(−/−)/Nox2(−/y) mice had reduced EC superoxide generation and greater aortic relaxation to acetylcholine. ESMIRO/ApoE(−/−)/Nox2(−/y) mice developed more lipid deposition in the thoraco-abdominal aorta with multiple foci of elastin fragmentation at the level of the aortic sinus and greater expression of intercellular adhesion molecule-1 (ICAM-1). Gp91dstat reduced EC superoxide and lipid deposition in the thoraco-abdominal aorta of ESMIRO/ApoE(−/−) mice without causing elastin fragmentation or increased ICAM-1 expression. These results demonstrate that insulin resistance is characterized by increased Nox2-derived vascular superoxide. Complete deletion of Nox2 in mice with EC insulin resistance exacerbates, whereas partial pharmacological Nox2 inhibition protects against, insulin resistance-induced vascular damage. American Physiological Society 2020-07-01 2020-05-13 /pmc/articles/PMC7468885/ /pubmed/32401607 http://dx.doi.org/10.1152/ajpcell.00389.2019 Text en Copyright © 2020 the American Physiological Society http://creativecommons.org/licenses/by/4.0/deed.en_US Licensed under Creative Commons Attribution CC-BY 4.0 (http://creativecommons.org/licenses/by/4.0/deed.en_US) : © the American Physiological Society. |
spellingShingle | Research Article Maqbool, Azhar Watt, Nicole T. Haywood, Natalie Viswambharan, Hema Skromna, Anna Makava, Natalia Visnagri, Asjad Shawer, Heba M. Bridge, Katherine Muminov, Shovkat K. Griffin, Kathryn Beech, David J. Wheatcroft, Stephen B. Porter, Karen E. Simmons, Katie J. Sukumar, Piruthivi Shah, Ajay M. Cubbon, Richard M. Kearney, Mark T. Yuldasheva, Nadira Y. Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage |
title | Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage |
title_full | Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage |
title_fullStr | Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage |
title_full_unstemmed | Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage |
title_short | Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage |
title_sort | divergent effects of genetic and pharmacological inhibition of nox2 nadph oxidase on insulin resistance-related vascular damage |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468885/ https://www.ncbi.nlm.nih.gov/pubmed/32401607 http://dx.doi.org/10.1152/ajpcell.00389.2019 |
work_keys_str_mv | AT maqboolazhar divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT wattnicolet divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT haywoodnatalie divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT viswambharanhema divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT skromnaanna divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT makavanatalia divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT visnagriasjad divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT shawerhebam divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT bridgekatherine divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT muminovshovkatk divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT griffinkathryn divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT beechdavidj divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT wheatcroftstephenb divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT porterkarene divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT simmonskatiej divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT sukumarpiruthivi divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT shahajaym divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT cubbonrichardm divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT kearneymarkt divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage AT yuldashevanadiray divergenteffectsofgeneticandpharmacologicalinhibitionofnox2nadphoxidaseoninsulinresistancerelatedvasculardamage |